Ex vivo transcriptional profiling reveals a common set of genes important for the adaptation of Pseudomonas aeruginosa to chronically infected host sites

Environmental Microbiology

Volumn 15, Issue 2, 2013, Pages 570-587

  Bielecki, Piotr ^a   Komor, Uliana ^b,g   Bielecka, Agata ^b   Müsken, Mathias ^a   Puchałka, Jacek ^b   Pletz, Mathias W ^c   Ballmann, Manfred ^d,e   Martins dos Santos, Vítor Ap ^b,f,g   Weiss, Siegfried ^b   Häussler, Susanne ^a,b  

^a INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c JENA UNIVERSITY HOSPITAL   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e RUHR UNIVERSITY BOCHUM   (Germany)

^f WAGENINGEN UNIVERSITY   (Netherlands)

^g LIFEGLIMMER GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; ANIMAL; ARTICLE; BIOFILM; CYSTIC FIBROSIS; ECOSYSTEM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; LUNG; MICROBIOLOGY; MOUSE; NEOPLASM; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; REGULATOR GENE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BIOFILMS; CYSTIC FIBROSIS; ECOSYSTEM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; GENE SILENCING; GENES, REGULATOR; HUMANS; LUNG; MICE; NEOPLASMS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

ANIMALIA; BACTERIA (MICROORGANISMS); MURINAE; PSEUDOMONAS AERUGINOSA;

EID: 84873123393     PISSN: 14622912     EISSN: 14622920     Source Type: Journal    
DOI: 10.1111/1462-2920.12024     Document Type: Article

References (58)

1. Alp, E., Coruh, A., Gunay, G.K., Yontar, Y., and Doganay, M. (2012) Risk factors for nosocomial infection and mortality in burn patients: 10 years of experience at a university hospital. J Burn Care Res 33: 379-385.
2. Banin, E., Vasil, M.L., and Greenberg, E.P. (2005) Iron and Pseudomonas aeruginosa biofilm formation. Proc Natl Acad Sci USA 102: 11076-11081.
3. de Bentzmann, S., and Plesiat, P. (2011) The Pseudomonas aeruginosa opportunistic pathogen and human infections. Environ Microbiol 13: 1655-1665.
4. Bielecki, P., Glik, J., Kawecki, M., and Martins dos Santos, V.A. (2008) Towards understanding Pseudomonas aeruginosa burn wound infections by profiling gene expression. Biotechnol Lett 30: 777-790.
5. Bielecki, P., Puchalka, J., Wos-Oxley, M.L., Loessner, H., Glik, J., Kawecki, M., etal. (2011) In-vivo expression profiling of Pseudomonas aeruginosa infections reveals niche-specific and strain-independent transcriptional programs. PLoS ONE 6: e24235.
6. Bjarnsholt, T., Tolker-Nielsen, T., Hoiby, N., and Givskov, M. (2010) Interference of Pseudomonas aeruginosa signalling and biofilm formation for infection control. Expert Rev Mol Med 12: e11.
7. Breitling, R., Armengaud, P., Amtmann, A., and Herzyk, P. (2004) Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 573: 83-92.
8. Choi, K.H., and Schweizer, H.P. (2005) An improved method for rapid generation of unmarked Pseudomonas aeruginosa deletion mutants. BMC Microbiol 5: 30.
9. Choi, K.H., Gaynor, J.B., White, K.G., Lopez, C., Bosio, C.M., Karkhoff-Schweizer, R.R., and Schweizer, H.P. (2005) A Tn7-based broad-range bacterial cloning and expression system. Nat Methods 2: 443-448.
10. Church, D., Elsayed, S., Reid, O., Winston, B., and Lindsay, R. (2006) Burn wound infections. Clin Microbiol Rev 19: 403-434.
11. Cornelis, P., Matthijs, S., and Van Oeffelen, L. (2009) Iron uptake regulation in Pseudomonas aeruginosa. Biometals 22: 15-22.
12. Cos, P., Tote, K., Horemans, T., and Maes, L. (2010) Biofilms: an extra hurdle for effective antimicrobial therapy. Curr Pharm Des 16: 2279-2295.
13. Costerton, J.W. (2001) Cystic fibrosis pathogenesis and the role of biofilms in persistent infection. Trends Microbiol 9: 50-52.
14. Costerton, J.W., Stewart, P.S., and Greenberg, E.P. (1999) Bacterial biofilms: a common cause of persistent infections. Science 284: 1318-1322.
15. Crull, K., Rohde, M., Westphal, K., Loessner, H., Wolf, K., Felipe-Lopez, A., etal. (2011) Biofilm formation by Salmonella enterica serovar Typhimurium colonizing solid tumours. Cell Microbiol 13: 1223-1233.
16. Dotsch, A., Eckweiler, D., Schniederjans, M., Zimmermann, A., Jensen, V., Scharfe, M., etal. (2012) The Pseudomonas aeruginosa transcriptome in planktonic cultures and static biofilms using RNA sequencing. PLoS ONE 7: e31092.
17. Fitzsimmons, L.F., Hampel, K.J., and Wargo, M.J. (2012) Intracellular choline and glycine betaine pools impact osmoprotection and phospholipase C production in Pseudomonas aeruginosa. J Bacteriol 194: 4718-4726.
18. Fothergill, J.L., Winstanley, C., and James, C.E. (2012) Novel therapeutic strategies to counter Pseudomonas aeruginosa infections. Expert Rev Anti Infect Ther 10: 219-235.
19. Fux, C.A., Stoodley, P., Hall-Stoodley, L., and Costerton, J.W. (2003) Bacterial biofilms: a diagnostic and therapeutic challenge. Expert Rev Anti Infect Ther 1: 667-683.
20. Fux, C.A., Costerton, J.W., Stewart, P.S., and Stoodley, P. (2005) Survival strategies of infectious biofilms. Trends Microbiol 13: 34-40.
21. Guina, T., Purvine, S.O., Yi, E.C., Eng, J., Goodlett, D.R., Aebersold, R., and Miller, S.I. (2003) Quantitative proteomic analysis indicates increased synthesis of a quinolone by Pseudomonas aeruginosa isolates from cystic fibrosis airways. Proc Natl Acad Sci USA 100: 2771-2776.
22. Harmsen, M., Yang, L., Pamp, S.J., and Tolker-Nielsen, T. (2010) An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal. FEMS Immunol Med Microbiol 59: 253-268.
23. Hassett, D.J., Korfhagen, T.R., Irvin, R.T., Schurr, M.J., Sauer, K., Lau, G.W., etal. (2010) Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies. Expert Opin Ther Targets 14: 117-130.
24. Hoang, T.T., Karkhoff-Schweizer, R.R., Kutchma, A.J., and Schweizer, H.P. (1998) A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212: 77-86.
25. Imperi, F., Ciccosanti, F., Perdomo, A.B., Tiburzi, F., Mancone, C., Alonzi, T., etal. (2009) Analysis of the periplasmic proteome of Pseudomonas aeruginosa, a metabolically versatile opportunistic pathogen. Proteomics 9: 1901-1915.
26. Klausen, M., Gjermansen, M., Kreft, J.U., and Tolker-Nielsen, T. (2006) Dynamics of development and dispersal in sessile microbial communities: examples from Pseudomonas aeruginosa and Pseudomonas putida model biofilms. FEMS Microbiol Lett 261: 1-11.
27. Komor, U., Bielecki, P., Loessner, H., Rohde, M., Wolf, K., Westphal, K., etal. (2012) Biofilm formation by Pseudomonas aeruginosa in solid murine tumors - a novel model system. Microbes Infect 14: 951-958.
28. Kuchma, S.L., and O'Toole, G.A. (2000) Surface-induced and biofilm-induced changes in gene expression. Curr Opin Biotechnol 11: 429-433.
29. Letoffe, S., Redeker, V., and Wandersman, C. (1998) Isolation and characterization of an extracellular haem-binding protein from Pseudomonas aeruginosa that shares function and sequence similarities with the Serratia marcescens HasA haemophore. Mol Microbiol 28: 1223-1234.
30. Liberati, N., Urbach, J., Miyata, S., Lee, D., Drenkard, E., Wu, G., etal. (2006) An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc Natl Acad Sci USA 103: 2833-2838.
31. Lim, C.K., Hassan, K.A., Penesyan, A., Loper, J.E., and Paulsen, I.T. (2012) The effect of zinc limitation on the transcriptome of Pseudomonas protegens Pf-5. Environ Microbiol. doi: 10.1111/j.1462-2920.2012.02849.x. [Epub ahead of print]
32. Makarova, K.S., Ponomarev, V.A., and Koonin, E.V. (2001) Two C or not two C: recurrent disruption of Zn-ribbons, gene duplication, lineage-specific gene loss, and horizontal gene transfer in evolution of bacterial ribosomal proteins. Genome Biol 2: RESEARCH 0033.
33. Munder, A., Krusch, S., Tschernig, T., Dorsch, M., Luhrmann, A., van Griensven, M., etal. (2002) Pulmonary microbial infection in mice: comparison of different application methods and correlation of bacterial numbers and histopathology. Exp Toxicol Pathol 54: 127-133.
34. Musken, M., Di Fiore, S., Dotsch, A., Fischer, R., and Haussler, S. (2010) Genetic determinants of Pseudomonas aeruginosa biofilm establishment. Microbiology 156: 431-441.
35. Nakada, Y., Nishijyo, T., and Itoh, Y. (2002) Divergent structure and regulatory mechanism of proline catabolic systems: characterization of the putAP proline catabolic operon of Pseudomonas aeruginosa PAO1 and its regulation by PruR, an AraC/XylS family protein. J Bacteriol 184: 5633-5640.
36. O'Toole, G.A., and Kolter, R. (1998) Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol 30: 295-304.
37. Owen, G.A., Pascoe, B., Kallifidas, D., and Paget, M.S. (2007) Zinc-responsive regulation of alternative ribosomal protein genes in Streptomyces coelicolor involves zur and sigmaR. J Bacteriol 189: 4078-4086.
38. Palmer, K.L., Mashburn, L.M., Singh, P.K., and Whiteley, M. (2005) Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J Bacteriol 187: 5267-5277.
39. Pompilio, A., Crocetta, V., Scocchi, M., Pomponio, S., Di Vincenzo, V., Mardirossian, M., etal. (2012) Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed alpha-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. BMC Microbiol 12: 145.
40. Ramsey, D.M., and Wozniak, D.J. (2005) Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis. Mol Microbiol 56: 309-322.
41. Ranall, M.V., Butler, M.S., Blaskovich, M.A., and Cooper, M.A. (2012) Resolving biofilm infections: current therapy and drug discovery strategies. Curr Drug Targets 13: 1375-1385.
42. Rybtke, M.T., Jensen, P.O., Hoiby, N., Givskov, M., Tolker-Nielsen, T., and Bjarnsholt, T. (2011) The implication of Pseudomonas aeruginosa biofilms in infections. Inflamm Allergy Drug Targets 10: 141-157.
43. Ryder, C., Byrd, M., and Wozniak, D.J. (2007) Role of polysaccharides in Pseudomonas aeruginosa biofilm development. Curr Opin Microbiol 10: 644-648.
44. Schaber, J.A., Triffo, W.J., Suh, S.J., Oliver, J.W., Hastert, M.C., Griswold, J.A., etal. (2007) Pseudomonas aeruginosa forms biofilms in acute infection independent of cell-to-cell signaling. Infect Immun 75: 3715-3721.
45. Schuster, M., Lostroh, C.P., Ogi, T., and Greenberg, E.P. (2003) Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: a transcriptome analysis. J Bacteriol 185: 2066-2079.
46. Schuster, M., Hawkins, A., Harwood, C., and Greenberg, E.P. (2004) The Pseudomonas aeruginosa RpoS regulon and its relationship to quorum sensing. Mol Microbiol 51: 973-985.
47. Shrout, J.D., Chopp, D.L., Just, C.L., Hentzer, M., Givskov, M., and Parsek, M.R. (2006) The impact of quorum sensing and swarming motility on Pseudomonas aeruginosa biofilm formation is nutritionally conditional. Mol Microbiol 62: 1264-1277.
48. Shrout, J.D., Tolker-Nielsen, T., Givskov, M., and Parsek, M.R. (2011) The contribution of cell-cell signaling and motility to bacterial biofilm formation. MRS Bull 36: 367-373.
49. Simon, R., Priefer, U., and Pühler, A. (1983) A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram negative bacteria. Biotechnology 1: 787-796.
50. Tart, A.H., and Wozniak, D.J. (2008) Shifting paradigms in Pseudomonas aeruginosa biofilm research. Curr Top Microbiol Immunol 322: 193-206.
51. Tummler, B., Bosshammer, J., Breitenstein, S., Brockhausen, I., Gudowius, P., Herrmann, C., etal. (1997) Infections with Pseudomonas aeruginosa in patients with cystic fibrosis. Behring Inst Mitt 98: 249-255.
52. Velasco-Garcia, R., Villalobos, M.A., Ramirez-Romero, M.A., Mujica-Jimenez, C., Iturriaga, G., and Munoz-Clares, R.A. (2006) Betaine aldehyde dehydrogenase from Pseudomonas aeruginosa: cloning, over-expression in Escherichia coli, and regulation by choline and salt. Arch Microbiol 185: 14-22.
53. Wagner, V.E., and Iglewski, B.H. (2008) P. aeruginosa biofilms in CF infection. Clin Rev Allergy Immunol 35: 124-134.
54. Wargo, M.J., Szwergold, B.S., and Hogan, D.A. (2008) Identification of two gene clusters and a transcriptional regulator required for Pseudomonas aeruginosa glycine betaine catabolism. J Bacteriol 190: 2690-2699.
55. Wehmhoner, D., Haussler, S., Tummler, B., Jansch, L., Bredenbruch, F., Wehland, J., and Steinmetz, I. (2003) Inter- and intraclonal diversity of the Pseudomonas aeruginosa proteome manifests within the secretome. J Bacteriol 185: 5807-5814.
56. Winsor, G.L., Lam, D.K., Fleming, L., Lo, R., Whiteside, M.D., Yu, N.Y., etal. (2011) Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res 39: D596-D600.
57. Yu, Q., Griffin, E.F., Moreau-Marquis, S., Schwartzman, J.D., Stanton, B.A., and O'Toole, G.A. (2012) In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells. J Antimicrob Chemother 67: 2673-2681.
58. Yukl, E.T., Jepkorir, G., Alontaga, A.Y., Pautsch, L., Rodriguez, J.C., Rivera, M., and Moenne-Loccoz, P. (2010) Kinetic and spectroscopic studies of hemin acquisition in the hemophore HasAp from Pseudomonas aeruginosa. Biochemistry 49: 6646-6654.